Home » News » Dr Reddy’s introduces generic Namenda in US markets

Dr Reddy’s introduces generic Namenda in US markets

Dr Reddy’s Laboratories has launched the United States Food & Drug Administration (FDA)  approved memantine hydrochloride tablets  USP, 5 mg and 10 mg, a therapeutic equivalent generic version of Namenda (memantine HCl) tablets in the US market on July  12, 2015.Dr-Reddy-Laboratories

The Namenda (memantine HCl) tablets brand had US sales of approximately $ 1.4 billion MAT for the most recent twelve months ending in May 2015 according to IMS Health.

Dr Reddy’s Memantine hydrochloride tablets USP, 5 mg is available in bottle count size of 60 and the memantine hydrochloride tablets USP, 10 mg are available in bottle count sizes of 60 and 500.

Don't be shellfish...Share on FacebookShare on Google+Share on LinkedInShare on StumbleUponPin on PinterestTweet about this on Twitter

Share and Enjoy

  • Facebook
  • Twitter
  • Delicious
  • LinkedIn
  • StumbleUpon
  • Add to favorites
  • Email
  • RSS

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Free WordPress Themes - Download High-quality Templates